Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Ana has a PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL), Portugal. She completed her post-doctoral research in Malaria with Prof. Maria Mota at Instituto de Medicina Molecular and Instituto Gulbenkian de Ciência for 6 years, and has served as a Staff Scientist in the T cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, where she continued studying malaria pathogenesis.

June 4, 2015June 5, 2015

Novel Data On PV-10 For Melanoma Treatment Presented At ASCO

News

New findings on PV-10, an investigational intra-lesional therapy for melanoma, were presented during the American Society of Clinical Oncology’s Annual Meeting on May 31, 2015, Chicago, Illinois, USA. The presentation entitled “A Changing Topography: ... Read more

March 24, 2015March 24, 2015

How Advanced Melanoma Treatments Can Improve Patient Survival

Melanoma, News

When melanoma is detected early, treatment can be highly successful. However, survival rates decrease significantly when cancer cells spread to the lymph nodes and other organs. In the last 5 years, targeted therapy and ... Read more

March 19, 2015March 19, 2015

Novel Immunotherapy Drug Pembrolizumab ‘Fast-Tracked’ for Advanced Melanoma

Melanoma, News

Under a new United Kingdom Government scheme, the novel immunotherapy drug Pembrolizumab has become the first treatment ‘fast-tracked’ for National Health Service (NHS) patients with advanced melanoma. “It’s a step ... Read more

March 11, 2015March 11, 2015

Radiation Combined With Immunotherapy May Provide Optimal Response For Metastatic Melanoma

Melanoma, News

A new treatment strategy combining radiation therapy and two immunotherapies that target the CTLA4 and PD-1 pathways was recently shown to induce an optimal response in patients with metastatic melanoma. ... Read more

February 16, 2015February 16, 2015

Researchers Pinpoint Chronic Inflammation In the Development of Skin Cancer

News, Skin Cancer

Inflammation is a process by which the immune system responds to a disease or injury. Chronic inflammation, however, has been linked to several types of cancers, such as basal cell carcinoma, lung, ... Read more

December 19, 2014December 19, 2014

Scientists Can Reprogram Skin Fibroblasts Into Melanocytes

News

A new study established a way to convert fibroblasts into functional melanocytes, the body’s pigment-producing cells. The study entitled “Direct conversion of mouse and human fibroblasts to functional melanocytes by ... Read more

October 1, 2014October 1, 2014

Melanoma, Immunotherapy-Radiation Combination Therapy Continues To Show Promise

News

A new study addressing the effect of highly focused radiation in boosting the immune system to target and kill cancer cells upon combination with a novel type of immune-enhancing drug, was presented ... Read more

September 25, 2014September 25, 2014

Results On New Melanoma Drug PV-10 To Be Presented At The European Society for Medical Oncology Congress

Melanoma, News

During this year’s European Society for Medical Oncology (ESMO) 2014 Congress, drug developer Provectus Biopharmaceuticals, Inc., will present a study entitled, “Subgroup efficacy in patients receiving intralesional rose bengal to all existing ... Read more